Dolutegravir

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2792 publications

Infectious Diseases: What You May Have Missed in 2025.

Infectious Diseases: What You May Have Missed in 2025.

Journal: Annals of internal medicine
Published: April 13, 2026

Simian Immunodeficiency Virus and Antiretroviral Therapy Impact Rhesus Macaque Brain Lipid Distribution.

Simian Immunodeficiency Virus and Antiretroviral Therapy Impact Rhesus Macaque Brain Lipid Distribution.

Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026

Virtual screening and cellular validation of dolutegravir as a BRD9 inhibitor for attenuating pyroptosis in peritoneal mesothelial cells.

Virtual screening and cellular validation of dolutegravir as a BRD9 inhibitor for attenuating pyroptosis in peritoneal mesothelial cells.

Journal: Renal failure
Published: April 07, 2026

Polycythemia in males living with HIV post dolutegravir and long term antiretroviral therapy.

Polycythemia in males living with HIV post dolutegravir and long term antiretroviral therapy.

Journal: International journal of STD & AIDS
Published: April 04, 2026

Exposure to Frontline Antiretroviral Dolutegravir Disrupts Oligodendrocyte Development Across Differentiation Stages.

Exposure to Frontline Antiretroviral Dolutegravir Disrupts Oligodendrocyte Development Across Differentiation Stages.

Journal: ASN neuro
Published: March 29, 2026

Kidney Dysfunction In Young People Living With HIV On Dolutegravir-Based Regimens In Kampala, Uganda.

Kidney Dysfunction In Young People Living With HIV On Dolutegravir-Based Regimens In Kampala, Uganda.

Journal: Research square
Published: March 27, 2026

HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya.

HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya.

Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026

High levels of elevated blood pressure among pregnant and postpartum women with HIV, regardless of dolutegravir initiation.

High levels of elevated blood pressure among pregnant and postpartum women with HIV, regardless of dolutegravir initiation.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 23, 2026

Efficient synthesis of 4-pyridone-3-carboxylic acids via the reaction of enaminated diketonates with primary amines.

Efficient synthesis of 4-pyridone-3-carboxylic acids via the reaction of enaminated diketonates with primary amines.

Journal: Organic & biomolecular chemistry
Published: March 23, 2026

Pharmacokinetics of Dolutegravir in Children with HIV with and without Tuberculosis Coinfection Treated According to World Health Organization Dosing Guidelines.

Pharmacokinetics of Dolutegravir in Children with HIV with and without Tuberculosis Coinfection Treated According to World Health Organization Dosing Guidelines.

Journal: Journal of acquired immune deficiency syndromes (1999)
Published: March 19, 2026

Association Between Waist Circumference to Body Mass Index Ratio and Elevated Serum Transaminases Among Patients on Dolutegravir-based Antiretroviral Therapy in South Western Uganda.

Association Between Waist Circumference to Body Mass Index Ratio and Elevated Serum Transaminases Among Patients on Dolutegravir-based Antiretroviral Therapy in South Western Uganda.

Journal: Journal of the International Association of Providers of AIDS Care
Published: March 13, 2026

Understanding the clinical implications of the barrier against resistance in antiretroviral treatment.

Understanding the clinical implications of the barrier against resistance in antiretroviral treatment.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 13, 2026
Showing 1-12 of 2,792

Last Updated: 04/28/2026